Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
glucose [2025/01/27 09:55] – admin | glucose [2025/01/27 10:54] (current) – admin | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ===== Glucose Examination Procedure ===== | + | |[[clinical_biochemistry_section|Home]]|[[clinical_biochemistry|]]|[[examination_procedures|]]| |
- | ^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH), | + | |
- | ^**Document Name**: | + | |
- | ^**Unique ID**: LSSTH/ | + | |
- | ^Issue No. : 01^Issue Date : | + | |
- | ^Authorized by: | + | |
- | |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | + | **1.Purpose of examination: |
- | + | ||
- | ==== Amendment Log1. ==== | + | |
- | ^Sr. No^ Date of Amendment^ Page & Clause Number of Amendment^ Amendment detail^ Reason for Amendment^ | + | |
- | |1 | | | + | |
- | + | ||
- | + | ||
- | ==== Purpose of examination: | + | |
- | + | ||
| | ||
- | ==== Responsibility and Authority: | + | **2. Responsibility and Authority:** |
Calibration: | Calibration: | ||
Line 25: | Line 13: | ||
Overall Monitoring: Quality Manager | Overall Monitoring: Quality Manager | ||
- | ==== Sample Details | + | **3.Sample Details** |
Type of Sample: | Type of Sample: | ||
Line 31: | Line 19: | ||
Type of container and additives: Sodium fluoride/ Potassium oxalate vaccutte, | Type of container and additives: Sodium fluoride/ Potassium oxalate vaccutte, | ||
- | Patient Preparation: | + | Patient Preparation: |
Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours | Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours | ||
Line 39: | Line 27: | ||
Storage: 24 hours at 2-8° C | Storage: 24 hours at 2-8° C | ||
- | === 4. Required Equipment: | + | **4. Required Equipment:** |
Centrifuge, Auto-Pipette, | Centrifuge, Auto-Pipette, | ||
- | === 5. Required reagents: | + | **5. Required reagents:** |
Line 90: | Line 78: | ||
- Verify calibration with at least two levels of controls | - Verify calibration with at least two levels of controls | ||
- If control results fall outside acceptable ranges,root cause analysis or recalibration may be necessary. | - If control results fall outside acceptable ranges,root cause analysis or recalibration may be necessary. | ||
- | + | **9. Quality control Procedure:** | |
- | === 10. Quality control Procedure: | + | |
1. Name: BioRad Level 1 & 2 | 1. Name: BioRad Level 1 & 2 | ||
Line 117: | Line 104: | ||
- Check IQC results, in case outliers call residents. | - Check IQC results, in case outliers call residents. | ||
- | === 11. Principle of the procedure used for examinations: | + | === 10. Principle of the procedure used for examinations: |
Glucose is phosphorylated by hexokinase (HK) in the presence of adenosine triphosphate (ATP) and magnesium ions to produce glucose‐6-phosphate (G‐6-P) and adenosine diphosphate (ADP). Glucose-6-phosphate dehydrogenase (G-6-PDH) specifically oxidizes G-6-P to 6-phosphogluconate with the concurrent reduction of nicotinamide adenine dinucleotide (NAD) to nicotinamide adenine dinucleotide reduced (NADH). One micromole of NADH is produced foreach micromole of glucose consumed. The NADH produced absorbs light at 340 nm and can be detected spectrophotometrically as an increased absorbance. | Glucose is phosphorylated by hexokinase (HK) in the presence of adenosine triphosphate (ATP) and magnesium ions to produce glucose‐6-phosphate (G‐6-P) and adenosine diphosphate (ADP). Glucose-6-phosphate dehydrogenase (G-6-PDH) specifically oxidizes G-6-P to 6-phosphogluconate with the concurrent reduction of nicotinamide adenine dinucleotide (NAD) to nicotinamide adenine dinucleotide reduced (NADH). One micromole of NADH is produced foreach micromole of glucose consumed. The NADH produced absorbs light at 340 nm and can be detected spectrophotometrically as an increased absorbance. | ||
- | === 12. Sample Preparation: | + | ===11.Sample Preparation: |
Required Sample Volume: 150 µl of the sample | Required Sample Volume: 150 µl of the sample | ||
Line 129: | Line 116: | ||
Take 150-200µl of the sample from Primary tube to examination. Write the sample ID on the aliquot. | Take 150-200µl of the sample from Primary tube to examination. Write the sample ID on the aliquot. | ||
- | === 13. Procedure to run Patient sample | + | **12. Procedure to run Patient sample** |
- Press Patient order | - Press Patient order | ||
Line 137: | Line 124: | ||
- Put respected carrier in RSH rack | - Put respected carrier in RSH rack | ||
- | === 14. Performance Characteristics: | + | **13. Performance Characteristics: |
1. Linearity: | 1. Linearity: | ||
Line 158: | Line 145: | ||
- | === 14. Normal and critical ranges: | + | **14. Normal and critical ranges:** |
^Parameter^Biological Reference Interval^Prediabetes^Diabetes^ | ^Parameter^Biological Reference Interval^Prediabetes^Diabetes^ | ||
Line 216: | Line 203: | ||
- Kaplan LA,Pesce AJ editors. Clinical Chemistry Theory Analysis, and Correlation, | - Kaplan LA,Pesce AJ editors. Clinical Chemistry Theory Analysis, and Correlation, | ||
- ARCHITECT | - ARCHITECT | ||
+ | |||
+ | |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | ||
+ | |||
+ | ^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH), | ||
+ | ^Document No.1^**Document Name**: Glucose Examination Procedure^**Unique ID**:LSSTH /BIOCHEM/ SOP-5^^ | ||
+ | ^Issue No. : 01^Issue Date : | ||
+ | ^Amend No.^ Amend Date ^Prepared by: Section Incharge^Approved & Issued by: HOD, | ||
+ | |||